The project was initially developed with support from Vinnova, Sweden’s public Innovation Agency and Oncorena was managed by GU Ventures at the University of Gothenburg. In 2013 Aqilion (formely P.U.L.S. AB) became the major shareholder and in 2016 the venture capital firm HealthCap made an investment via a rights issue. Read more about Aqilion and HealthCap.
|Company name:||Oncorena AB / Oncorena Holding AB|
|Swedish corporate identity numbers:||556864-0808 / 556925-5192|
|Founded:||Helsingborg, Sweden, in 2011|
|Address:||Scheelevägen 2, Medicon Village, 223 63 Lund, Sweden|